Cargando…
From General Aberrant Alternative Splicing in Cancers and Its Therapeutic Application to the Discovery of an Oncogenic DMTF1 Isoform
Alternative pre-mRNA splicing is a crucial process that allows the generation of diversified RNA and protein products from a multi-exon gene. In tumor cells, this mechanism can facilitate cancer development and progression through both creating oncogenic isoforms and reducing the expression of norma...
Autores principales: | Tian, Na, Li, Jialiang, Shi, Jinming, Sui, Guangchao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5372486/ https://www.ncbi.nlm.nih.gov/pubmed/28257090 http://dx.doi.org/10.3390/ijms18030191 |
Ejemplares similares
-
Mechanisms regulating DMTF1β/γ expression and their functional interplay with DMTF1α
por: Li, Jialiang, et al.
Publicado: (2020) -
Aberrant mRNA splicing generates oncogenic RNA isoforms and contributes to the development and progression of cholangiocarcinoma
por: Yosudjai, Juthamas, et al.
Publicado: (2019) -
MicroRNA-155 promotes bladder cancer growth by repressing the tumor suppressor DMTF1
por: Peng, Yang, et al.
Publicado: (2015) -
miR-675 promotes colorectal cancer cell growth dependent on tumor suppressor DMTF1
por: Yang, Xueliang, et al.
Publicado: (2019) -
EASI—enrichment of alternatively spliced isoforms
por: Venables, Julian P., et al.
Publicado: (2006)